Physician profile
Damon Armstrong
NPI 1548400500
$6,991.58
in general payments reported to CMS, 2019-2025
7 companies · $55.05 in 2025
The $55.05 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,230 · 2022: $2,536 · 2023: $37.86 · 2024: $132 · 2025: $55.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,788.23 | 2019-2024 | Da Vinci Surgical System |
| Baxter Healthcare | $107.59 | 2024 | Perclot |
| Smith+Nephew, INC. | $32.82 | 2024-2025 | Collagenase Santyl |
| Biocomposites INC | $19.67 | 2025 | Stimulan |
| Boston Scientific Corporation | $16.63 | 2025 | Varithena Administration Pack |
| Kowa Pharmaceuticals America, INC. | $13.92 | 2022 | |
| Tela Bio, INC. | $12.72 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damon Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.